eyeonics secures $16.2m in private money to revamp up crystalens sales
This article was originally published in Clinica
Executive Summary
The developer of the first FDA-approved accommodating intraocular lens, eyeonics, has raised $16.2m in its fifth round of financing led by a new investor, Versant Ventures of Menlo Park, California. The proceeds will be used to expand eyeonics' distribution force for its crystalens product to encompass around 100 employees during 2006.